Login to Your Account

Strong deal flow brings in more than $1B in venture capital

By Peter Winter

Monday, April 7, 2014

A robust deal flow defined the first quarter of the year, which saw 60 global private biotech companies generate more than $1 billion. Not a bad haul and two and half times the amount generated in the same period last year from 45 deals.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription